Efficacy of virtual reality assisted breathing therapy for pain and anxiety relief in patients with cancer receiving systemic chemotherapy
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0009588
- Lead Sponsor
- GangNeung Asan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Among patients with liver cancer, biliary tract cancer, and pancreatic cancer aged 19 years or older who are undergoing systemic chemotherapy, patients who voluntarily agree in writing to participate in this study using VR therapy are targeted.
Exclusion Criteria
Patients with cognitive decline, vision (including color perception) or hearing loss, or facial defect, damage or deformity, brain damage, or epilepsy that are not suitable for applying VR are excluded.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method